Page 227 - Markets News

Choice Gold ETF NFO opens today: Here's everything investors should know

The NFO is benchmarked against the domestic price of gold. According to the SID, the risk of the fund, as well as the benchmark, is high

Vedanta shares advance 3% on ₹1-trillion Odisha investment plan

Vedanta shares rose 3 per cent after it said it will invest an ₹1 trillion in Odisha, helping create over 1 lakh employment opportunities

Bondada Engineering shares rise 3% on receiving LoI from Adani Group

The buying on the counter came after the company secured a letter of intent (LOI) from Adani Group

Here's why Sammaan Capital shares rose 5% to hit 52-week high on bourses

The company's stock price advanced 4.90 per cent to reach a 52-week high of ₹182.95 per share on the BSE after the company announced that it had made timely payment of interest on its NCDs

Laurus Labs shares drop 3% despite analysts' bullish outlook; details here

Laurus Labs reported a strong Q2 FY26 performance, with consolidated net profit soaring multifold to ₹194.97 crore, compared with ₹19.78 crore in Q2 FY25

Hindalco rallies 4%, at new high; what's driving Aditya Birla Group stock?

In the past one month, Hindalco has outperformed the market by gaining 11 per cent, as compared to 3.4 per cent rise in the BSE Sensex; here are the key reasons behind the rally.

Insolation Energy up 8% on board nod to shift from SME to main board

The buying on the counter came after the company's board approved the migration of equity shares from the SME category to the mainboard (BSE, NSE)

Orkla India sets IPO price band at ₹695-730; check key dates, lot size

Orkla India IPO will open for subscription on Wednesday, October 29, 2025, and close on Friday, October 31, 2025

South India Paper Mills hits 20% upper circuit on posting Q2 results

In the second quarter (Q2FY26), South India Paper Mills reported a net profit of ₹2.8 crore, as against the loss of ₹1.21 crore a year ago.

Asian shares rise as US earnings, Trump-Xi meeting boost investor sentiment

As the US government shutdown blots out most economic data, the spotlight is on Friday's consumer price figures for signals about next week's policy meeting at the Federal Reserve

Midwest makes positive D-St debut; shares list at 10% premium on bourses

Midwest stock opened at ₹1,165.1 on BSE, a premium of 10 per cent. Post-listing, it hovered around ₹1,174

Epack Prefab Technologies shares soar 8% to hit fresh high; here's why

In the last two trading sessions, the Epack Prefab Technologies shares have appreciated by around 24.55 per cent.

PTC India Financial share skyrockets 15% on healthy Q2 results; details

PTC India Financial shares rallied on the back of a healthy set of numbers in the September quarter of financial year 2026 (Q2FY26).

Antique sees 'tremendous' scope in ₹2.5-trn worth FY26 defence proposals

On Thursday, the MoD said the Defence Acquisition Council approved procurement proposals worth ₹79,000 crore

HUL, Colgate or Nestle? 2 of these 3 FMCG stocks can gain up to 15%: charts

FMCG Stock Today: Technical charts show that Hindustan Unilever and Nestle India seem to be favourably placed; while Colgate Palmolive stock can decline up to 7% from here.

Rupee extends winning streak despite rising oil prices; opens at 87.79/$

Indian Rupee today: The domestic currency opened five paise higher at 87.79 against the greenback on Friday

HUL Q2: Analysts see near-term GST drag, recovery in H2; buy or sell?

Analysts believe that goods and services tax (GST) cuts weighed on both revenue and margins and will continue to do so into Q3FY26

Maruti, M&M top Motilal Oswal picks; auto ancillaries see split sentiments

Tariff uncertainty, analysts believe, continues to cloud the outlook for auto ancillaries, affecting CV components and non-auto exports.

Stocks to Watch today: Colgate, HUL, Defence stocks, NTPC Green, Cipla, Vi

Stocks to Watch today: Colgate, Hindustan Unilever, Defence stocks, Vedanta, Kaynes Technology, NTPC Greent, and Indian Hotels are among the stocks to watch today, October 24, 2025

Nuvama retains 'Hold' on Cipla, raises target after Eli Lilly diabetes deal

Cipla- Eli Lilly deal: Tirzepatide is a prescription drug used for managing type 2 diabetes and aiding weight loss in adults who are obese or overweight.